Back

Analysis of safety and outcome of use of NOAC in intracardiac thrombi over warfarin

1 September 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: Clinical and experimental arrhythmia treatments Treatment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Omar Al-assaf

Dubai Hospital and Rashid Hospital, Dubai (United Arab Emirates)

8 More presentations in this session

Presentation thumbnail
Efficacy and safety of ultrasound guided stellate ganglion block: developing new clinical indications beyond electrical storm
Doctor A. Morena (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Atrial and ventricular arrhythmias in young, lifelong and retired elite endurance athletes
Doctor P. D'Ambrosio (Fitzroy, AU)
Abstract Slides Video
Presentation thumbnail
Amiodarone-related thyroid dysfunction and associated outcomes in patients with heart failure - a matched case-control study
Doctor S. Ali (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Association between preprocedural thromboembolic or bleeding events under oral anticoagulation therapy and mid-term outcomes after percutaneous left atrial appendage closure
Doctor H. Sumiyoshi (Kamogawa, JP)
Abstract Slides Video
Presentation thumbnail
BA6b9, a novel sk4 K + channel blocker, attenuates atrial fibrillation substrate in rats with reduced ejection fraction
Mr O. Levi (Beer Sheva, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical and experimental arrhythmia treatments

The Event

Event poster

ESC Congress 2024

1 September 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
The efficacy and safety of direct oral anticoagulants compared to warfarin for LV thrombus resolution
thumbnail
Congress Presentation
Direct oral anticoagulants versus warfarin for left ventricular thrombus
thumbnail
Congress Presentation
Initiation of warfarin is associated with decreased mortality in patients with infective endocarditis: a population based cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources